Share
Preview
Experts ring in on long haul COVID, Immunology and Peptides
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
 
TWO HOUR COMPLIMENTARY EVENT COMING DECEMBER 16, 2021
Dr. Ahvie Herskowitz presents: State of the Art COVID Update -
Status, Mechanisms and Strategic Thinking

&
Dr. Suzanne Turner presents: The Use of Peptides and Other Therapies to
Modulate and Optimize Immune Function

We wake up almost every morning to new information that often contains conflicting data, and offers little guidance we can offer our patients with confidence. Tune in Thursday, December 16th for another of our series of State-of-the-Art COVID updates.
The first segment; presented by Dr. Ahvie Herskowitz, will summarize our current status in terms of regional burdens of hospitalizations, vaccine/booster updates and adverse events, a review of immune mechanisms involved post-viral autoimmunity, long COVID syndromes, and evidence based treatment strategies for viral infections.
The second segment; presented by Dr. Suzanne Turner, will review immune mechanisms involved in virally mediated morbidity and mortality. As well as emphasize the potential role of peptide therapies to modulate and optimize immune function.

 
TRENDING NEWS
ACAM EDUCATION & EVENTS
December 16, 2021
Dr. Ahvie Herskowitz on Immunology of COVID and Long COVID
&
Dr. Suzanne Turner on Peptides for Immune Modulation

January 19, 2022
Jacques Simon, esq
Legal Webinar

February 12, 2022
Chelation Module 2

April 16, 2022
Dr. Gregory Smith
CBD for Healthcare Professionals
 
POLICY & ADVOCACY
Natural Medicine and COVID: Will Congress Help?
Real COVID prevention means addressing the obesity and chronic disease epidemic, but the feds don't have a clue.
COVID has killed more than 750,000 Americans and caused more than three million hospitalizations. Yet the virus is not an indiscriminate killer. We know that people with underlying conditions like obesity, diabetes, and heart disease are far more likely to experience the worst effects of COVID if they become infected. Addressing the chronic disease epidemic would take us a long way in addressing the COVID-19 pandemic, but the government is totally lost on this point. Part of this plan should be to make dietary supplements more available to Americans, which is accomplished by new federal legislation—we must support it.
 

American College for Advancement in Medicine
380 Ice Center Lane, Ste C | Bozeman, MT
acam.org | 800.532.3699 | info@acam.org
 
 
 


Email Marketing by ActiveCampaign